Introduction
Neuregulin (NRG) 1 is widely known to play an essential role in the heart and nervous system, where it orchestrates vital cell functions such as mitogenesis and differentiation (Meyer and Birchmeier, 1995) . However, emerging evidence suggests the involvement of NRG1 signalling in the development and function of other organ systems as well as in the pathogenesis of breast cancer and schizophrenia (Falls, 2003) . NRG1 mediates its effects via binding to members of the erythroblastoma (ErbB) family, consisting of epidermal growth factor receptor (EGFR)/ErbB1, ErbB2, ErbB3 and ErbB4. The latter two represent the bona fide receptors for NRG1 (Mei and Xiong, 2008) . Upon ligand engagement, ErbB receptors undergo homo-or heterodimerization, which is followed by auto-and transphosphorylation of intracellular tyrosine residues and the recruitment of adaptor proteins. The phosphatidylinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway as well as the mitogen-activated protein kinase (MAPK) cascade frequently participate in ErbB signalling to govern distinct cell fate decisions (Citri and Yarden, 2006) . ErbB3 is a non-autonomous receptor with an impaired tyrosine kinase domain and thus homodimers are catalytically inactive (Guy et al., 1994) . The ligand-less ErbB2 receptor always exists in an untethered conformation poised to dimerize with another receptor and therefore acts as the preferred heterodimerization partner of all other family members (Garrett et al., 2003) .
Remarkably, ErbB2/ErbB3 heterodimers represent the most potent signalling complexes and function as an oncogenic unit implicated in cell cycle progression, survival, angiogenesis and metastasis (Ursini-Siegel et al., 2007) . To date, a physiological role of ErbB2/ErbB3 signalling has only been described in murine neurons (Britsch et al., 1998) . A recent publication by our laboratory identified human trophoblast subtypes to specifically express ErbB2 and ErbB3, while being devoid of EGFR and ErbB4 (Fock et al., 2015) . These data point to a physiological function of the NRG1/ErbB2/ErbB3 axis during placental development in humans.
Trophoblasts are specialized cells of the placenta and play a crucial role in implantation, nutrient supply of the foetus and its immune tolerance in an allogeneic environment (Moffett and Loke, 2006) . Placental villi, the basic structural units of the human placenta, are composed of an outer syncytiotrophoblast and an inner villous cytotrophoblast (CTB) layer surrounding the stromal core. In the course of placentation, villous CTBs give rise to cells of the extravillous trophoblast (EVT) lineage, which infiltrate the decidualized endometrium and remodel local arteries to establish a foeto-maternal circulation (Pijnenborg et al., 1980) . EVT formation is initiated by increased villous CTB proliferation, leading to the emergence of Journal of Cell Science • Advance article multilayered cell columns at the tips of anchoring villi contacting the decidua. At their very proximal end, cell columns comprise proliferative EGFR + cell column trophoblasts (CCTs), which continuously differentiate into non-dividing trophoblasts forming the distal part of nascent columns. The latter acquire an invasive phenotype, characterized by the upregulation of specific marker genes such as human leukocyte antigen (HLA)-G (Ellis et al., 1990) , T-cell factor (TCF) 4 (Pollheimer et al., 2006) , integrin alpha (ITGA) 1 and -5 (Damsky et al., 1992) , as well as various matrix metalloproteinases (MMPs) (Fisher et al., 1989) .
The development of the EVT lineage is tightly controlled by a myriad of factors and failure of this process is associated with severe pregnancy disorders including preeclampsia and foetal growth restriction (Brosens et al., 1977; Brosens et al., 1970) . In the light of the manifold cellular functions modulated by the ErbB network, we hypothesized that ErbB2 and ErbB3 might represent important regulators of EVT formation. Hence, it was the scope of the present study to unravel functional aspects of this oncogenic receptor combination during human placental development.
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Results
Decidua-derived signals activate ErbB3 and related downstream kinases in primary trophoblasts
We have recently shown that EVT formation is accompanied by the acquisition of a specific receptor tyrosine kinase (RTK) signature, including fibroblast growth factor receptor 1 and -3, Fms-related tyrosine kinase 1 and -4, as well as ErbB2 and ErbB3 (Fock et al., 2015) . Given the close spatial relationship between the EVT lineage and cells within the decidua, we reasoned that signalling molecules derived from maternal tissue would influence the activation status of these receptors in a paracrine manner. To this end, we stimulated primary trophoblasts with conditioned medium harvested from overnight-cultivated decidual stromal cells (DSCs) and performed a phospho-RTK array. Indeed, ErbB3 was strongly phosphorylated at tyrosine residues in the presence of DSC-conditioned medium, whereas the activation status of other receptors remained unaffected. Furthermore, a pronounced phosphorylation of the downstream effectors Akt at S473, extracellular signal-regulated kinase (ERK) at T202/Y204 and ribosomal protein S6 (RPS6) at S235/236 could be observed ( Fig. 1A ). Measurement of pixel intensities revealed significantly increased levels of phosphorylated ErbB3, Akt, ERK and RPS6 after 5 and/or 20 min of stimulation, respectively ( Fig. 1B ).
NRG1 is released by DSCs and triggers phosphorylation of ErbB2 and ErbB3 in primary trophoblasts
In an attempt to explain the observed effects on the phosphorylation status of ErbB3, we analyzed the expression profile of the well-characterized ErbB3 ligand NRG1 in DSCs. Realtime PCR revealed significantly elevated NRG1 mRNA levels in primary DSCs when compared to overnight-cultivated trophoblasts ( Fig. 2A ). Furthermore, a NRG1-specific immunoreactive band could be detected in lysates of cultivated DSCs and DSC-conditioned medium by Western blotting (Fig. 2B ). Immunofluorescence stainings of first trimester decidual tissue confirmed NRG1 expression by vimentin + DSCs. Interestingly, NRG1 localized both to the nucleus and the cell membrane ( Fig. 2C ). We then asked whether treatment of primary trophoblasts with recombinant human (rhu) NRG1 would mirror the phosphorylation pattern observed with DSC-conditioned medium. Strikingly, we could detect analogous effects of rhu NRG1 and DSC-derived medium on the activation status of ErbB3, Akt, ERK, mammalian target of rapamycin (mTOR) and S6 kinase (S6K), the upstream Journal of Cell Science • Advance article activator of RPS6. Moreover, we noticed a marked phosphorylation of ErbB2 at Y1221/1222 upon stimulation with rhu NRG1 and DSC-conditioned medium ( Fig. 2D ). Further analyses with antibodies recognizing two additional phosphorylation sites (Y788, Y1248) confirmed NRG1-driven activation of ErbB2 ( Supplementary Fig. 1A ). These results indicate that decidua-derived NRG1 acts on trophoblasts in a paracrine manner to activate ErbB2, ErbB3
and downstream signal transduction pathways.
ErbB2 and ErbB3 form a functional unit in HLA-G + trophoblasts upon stimulation with NRG1
Based on our findings, we assumed that ErbB2 and ErbB3 are co-expressed and able to form functional heterodimers in human trophoblasts. To address this question, we performed double immunofluorescence stainings on serial sections of first trimester placental tissue.
Both receptors were strongly expressed by EGFR -/HLA-G + CCTs and indeed showed a significant co-localization in the respective trophoblast population (Fig. 3A ). In concert with our immunofluorescence data, flow cytometry of primary trophoblasts confirmed that HLA-G expression precludes EGFR and ErbB4 positivity and cells stained positive for HLA-G/ErbB2
(65.4%) or HLA-G/ErbB3 (54.1%). Importantly, 52.9% of cells were double positive for both receptors ( Fig. 3B and data not shown). Furthermore, co-immunoprecipitation analyses revealed ErbB2/ErbB3 interactions in the presence of rhu NRG1, suggesting heterodimerization of the two receptors upon ligand binding ( Fig. 3C ). To interfere with NRG1-mediated receptor dimerization, we transfected primary trophoblasts with siRNAs targeting ErbB2 or ErbB3 and determined their activation status. Phosphorylation of the respective receptors by rhu NRG1 was effectively diminished in cells subjected to singleknockdowns. Accordingly, activation of the downstream effectors Akt and ERK was remarkably decreased (Fig. 3D ). In agreement with these results, blockage of ErbB3 with a monoclonal antibody (ErbB3 mAb) led to a sustained decrease in NRG1-mediated phosphorylation of ErbB2 and ErbB3, as well as of Akt and ERK ( Fig. 3E and Supplementary   Fig. 1A ). Of note, the optimal concentration of the ErbB3 blocking antibody was determined by measuring dose-and time-dependent phosphorylation levels of ErbB3 and Akt in primary trophoblasts ( Supplementary Fig. 1B ). Altogether, these findings strongly support the formation of signalling-competent ErbB2/ErbB3 heterodimers in differentiated HLA-G + trophoblasts.
Journal of Cell Science • Advance article
NRG1 promotes EVT formation in placental explant cultures
Development of the EVT lineage involves a sequential series of steps including cell proliferation, differentiation and invasion. These processes are mimicked by placental tissue explants forming proliferative cell columns that differentiate into invasive EVTs (Genbacev et al., 1992) . To determine the biological function of NRG1-induced ErbB2/ErbB3 signalling, we first assessed its effect on placental floating explants cultivated in serum-free medium.
Interestingly, treatment with rhu NRG1 caused a dose-dependent increase in the HLA-G + area of cell columns when compared to vehicle-treated controls (Fig. 4A,B ). Additionally, we monitored the influence of rhu NRG1 on placental explants grown on Collagen-I and found that trophoblast outgrowth was significantly increased in the presence of the ligand (Fig.   4C ,D). Of note, neither trophoblast cell proliferation nor invasion were affected by rhu NRG1
in any of the model systems used ( Supplementary Fig. 2 ). In a next step, we purified RNA from both control-and rhu NRG1-treated explants and analyzed the expression levels of EVT differentiation markers by RT-PCR. Two-way ANOVA revealed a significant general effect (p<0.001) of rhu NRG1 on EVT marker expression ( Fig. 4E ). Further analyses with shortterm rhu NRG1-stimulated primary trophoblasts suggested that none of these genes are direct transcriptional targets of NRG1 signalling ( Supplementary Fig. 3 ).
NRG1 protects differentiated trophoblasts from camptothecin-induced apoptosis
Programmed cell death has been shown to play a crucial role for placental morphogenesis and normal trophoblast function . This is also reflected by deregulated apoptosis rates in EVTs in the context of preeclampsia and foetal growth restriction Genbacev et al., 1999; Smith et al., 1997) . To clarify the mechanism of NRG1-dependent EVT formation, we assessed the effect of rhu NRG1 on cell survival. To this end, we treated placental floating explants with rhu NRG1 in the presence or absence of the topoisomerase I inhibitor camptothecin (CPT) and evaluated apoptosis rates by means of M30 CytoDEATH stainings ( Fig. 5A ). In regard to the cell column, our quantifications showed that 5.4 ± 1.4% of CCTs underwent apoptosis in the vehicle-treated control.
Interestingly, rhu NRG1 treatment alone was sufficient to profoundly decrease apoptosis rates below baseline levels. Upon addition of CPT, the rate of apoptosis was raised to 22.6 ± 4.9%
and significantly reduced in the presence of rhu NRG1. This NRG1-dependent protective effect was abolished upon antibody-mediated blockage of ErbB3. As expected, rhu NRG1 did not affect CPT-induced apoptosis of ErbB2 -/ErbB3villous CTBs (Fig. 5B ). In concert, we Journal of Cell Science • Advance article could show by Western blotting that CPT-treated primary trophoblasts did respond to rhu NRG1 by markedly diminished levels of cleaved caspase 3, its downstream target caspasecleaved cytokeratin 18 (recognized by the M30 antibody) and p53. This effect was again abrogated upon neutralization of ErbB3 (Fig. 5C ). Together, these findings point to a pronounced anti-apoptotic effect of NRG1 on human trophoblasts.
Suppression of apoptosis by NRG1 stabilizes the differentiated CCT population
To assess further the possibility that NRG1-dependent EVT formation results from protection against apoptotic cell death, we quantified HLA-G + cell column areas of placental floating explants treated with CPT and/or rhu NRG1 (Fig. 6A ). In the presence of CPT, the HLA-G + area of cell columns was decreased more than twofold when compared to the vehicle-treated control. Of note, rhu NRG1 could inhibit CPT-induced apoptosis and cell columns were comparable to healthy controls. Finally, when explant cultures were pre-incubated with the ErbB3 blocking antibody to counteract NRG1 signalling, cell columns were diminished in size and values were similar to those of CPT treatment alone ( Fig. 6B ). Collectively, our data implicate that NRG1-mediated ErbB2/ErbB3 signalling leads to the suppression of apoptosis, thereby protecting the pool of differentiated CCTs (Fig. 7) .
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Discussion
In this study we show that decidua-derived NRG1 induces the formation of ErbB2/ErbB3 heterodimers in HLA-G + trophoblast subtypes. Downstream signalling involves the activation of PI3K/Akt/S6K and MAPK/ERK pathways. Together, our functional data indicate that NRG1 promotes the survival of differentiated CCTs via suppression of apoptotic cell death.
We further propose that the NRG1/ErbB2/ErbB3 axis is required for the maintenance of the distal cell column in order to ensure an adequate decidual invasion by EVTs (Fig. 7) .
The majority of data describing a functional role of ErbB2/ErbB3 heterodimers has been generated in mouse models of tumour progression. These efforts have led to the classification of this receptor complex as an oncogenic unit owing to the transforming potential of ErbB2
and ErbB3 when co-expressed (Holbro et al., 2003; Junttila et al., 2009; Zhang et al., 1996) .
In fact, the only data available to suggest a physiological function for the respective receptor combination demonstrate a pivotal role of NRG1-induced ErbB2/ErbB3 signalling during the development of the sympathetic nervous system in mice (Britsch et al., 1998) . Interestingly, homozygous deletions of ErbB2, ErbB3 and NRG1 result in embryonic lethality, a phenotype often accompanied by placental defects (Meyer and Birchmeier, 1995; Natale et al., 2006; Riethmacher et al., 1997) . Although the placenta has not been examined in ErbB2-, ErbB3-or NRG1-null mice, it is noteworthy that murine trophoblast giant cells, which are the equivalent to invasive EVTs in humans, were found to express both ErbB2 and ErbB3 (Dackor et al., 2007; Lim et al., 1997) . In addition, a recent study points to a role for ErbB2/ErbB3-mediated signalling at distant sites other than the nervous system such as the upper spinous layers of the skin (Piepkorn et al., 2003) . Well in line with our own published data (Fock et al., 2015) , it seems obvious that during physiological processes, expression of ErbB2 and ErbB3 is restricted to differentiated non-dividing cell populations, most likely due to the transforming potential of ErbB2/ErbB3 heterodimers (Holbro et al., 2003 Regarding the cellular source of NRG1, our results demonstrate that DSCs express and secrete the ligand in situ and in vitro, respectively. This finding is in accordance with a study reporting NRG1 expression in uterine glands and stromal cells of the non-pregnant endometrium (Srinivasan et al., 1999) . In contrast, primary trophoblasts show no or very little expression of the ErbB3 ligand, speaking against autocrine effects. The NRG1 gene encodes a huge variety of isoforms, which are produced by alternative splicing and promoter usage (Mei and Nave, 2014) . Although these variants differ in their amino-terminal sequence, they all share a conserved EGF-like domain responsible for receptor activation (Jones et al., 1998) .
Which particular NRG1 isoforms are expressed by DSCs awaits further investigation since the antibody used in this study was raised against the EGF-like domain. Due to its expression as transmembrane pro-form, activation of NRG1 requires proteolytic shedding by a disintegrin and metalloproteinase (ADAM) such as ADAM10, -17 and -19 or beta-site amyloid precursor protein-cleaving enzyme (BACE) 1 (Fleck et al., 2013; Luo et al., 2011; Yokozeki et al., 2007) . Available data on NRG1-processing sheddases in the foeto-maternal interface indicate BACE1 expression in DSCs (Buhimschi et al., 2014) and associate EVTs with a strong upregulation of certain ADAM family members, including ADAM19 . These data imply that NRG1 activation can potentially be triggered by DSCs in an intrinsic manner or upon cell-cell contact with invasive EVTs via ADAMmediated cleavage. Besides its expected localization at the cell membrane, NRG1 is also present within the nucleus of DSCs. Although not scope of this study, it seems likely that the NRG1 intracellular domain plays a role in DSC functions by acting as transcriptional regulator, which has already been reported in neurons (Bao et al., 2003) .
To elucidate the biological effects of NRG1-induced ErbB2/ErbB3 signalling, we took advantage of various different human trophoblast model systems. Placental explants maintained in serum-free medium or grown on Collagen-I mimic EVT differentiation by the formation of proliferative cell columns, which give rise to invasive EVTs. These cultivation methods of placental explants allow the examination of trophoblast behaviour without the presence of multiple exogenous cytokines, growth factors and binding proteins that could potentially influence cell kinetics. Also, the spatial and ontological relationship between cells is maintained. In addition, primary trophoblast cultures comprising a pool of EGFR + and HLA-G + subtypes were used in this study. During the first 24 h of culture, primary trophoblasts cease proliferation and differentiate along the extravillous pathway, which is reflected by an increased expression of EVT marker genes Pollheimer et al., 2011) . Our data indicate that NRG1 strongly promotes the formation of Journal of Cell Science • Advance article HLA-G + cell columns in placental floating explants as well as trophoblast outgrowth in explants grown on Collagen-I. In addition, NRG1 enhances the expression of EVT-associated marker genes in outgrowing explants in an indirect manner, since gene transcription remained unaffected after short-term exposure to exogenous NRG1.
The vast majority of reports describe a pivotal function of ErbB2/ErbB3 heterodimers in cancer cell proliferation or motility (Holbro et al., 2003; Lyons et al., 2005) . Unexpectedly, NRG1 does not influence these processes in any of the trophoblast model systems used. In this context, it is interesting to note that studies concentrating on ligand-independent ErbB2 or NRG1 signalling alone do suggest an additional role in cell survival (Andrechek et al., 2002; Zhao et al., 1998) . Indeed, our present data indicate that NRG1 suppresses basal as well as CPT-induced apoptosis in CCTs. Consequently, we asked whether CPT treatment would negatively interfere with EVT formation and if so, whether NRG1 would inhibit this effect.
Strikingly, we could observe that NRG1 protects HLA-G + trophoblasts from CPT-induced apoptosis, resulting in a significant stabilization of trophoblast cell columns. In agreement, placental explants treated with an ErbB3 blocking antibody undergo apoptosis due to a lack of NRG1-mediated survival signals, which is also reflected by a remarkably decreased cell column area.
Development of the HLA-G + EVT lineage involves a series of cellular events including mitogenesis, differentiation and the induction of an epithelial-to-mesenchymal transition, allowing for an adequate trophoblast invasion into the decidua . In this regard, our findings support a novel concept bridging NRG1-dependent apoptotic resistance in ErbB2 + /ErbB3 + CCTs with differentiation and EVT formation during early pregnancy. Downstream targets of the NRG1/ErbB2/ErbB3 axis include AKT, mTOR, S6K and ERK, all of which are related to survival in various cell types and model systems (Kennedy et al., 1997; Xia et al., 1995) . Interestingly, a study using constitutively active v- (Fock et al., 2015) .
Collectively, our findings imply a vital role for tissue-resident DSCs in the paracrine control of trophoblast behaviour. Recent data substantiate this concept by demonstrating a supportive role of uterine natural killer (uNK) cells or uteroplacental macrophages in regulating Journal of Cell Science • Advance article trophoblast functions. While uNK cells promote EVT invasion by the production of certain chemokines and growth factors (Hanna et al., 2006) , macrophages enhance placental growth via secretion of interleukin-33 (Fock et al., 2013) . Although a well-balanced degree of apoptosis likely plays a critical role during trophoblast differentiation , there is evidence to suggest that enhanced rates of cell death in various trophoblast subtypes are indicative for pregnancy pathologies (Sharp et al., 2010) . In this context, increased EVTassociated apoptosis has been noticed in sections of placental bed biopsies obtained from patients with severe preeclampsia Kadyrov et al., 2006) . Another group postulates that outgrowing placental explants from high-resistance pregnancies are more susceptible to apoptotic stimuli than those from normal-resistance pregnancies in vitro (Whitley et al., 2007) . In agreement, phenotypical alterations in different decidual cell types have been linked to placental pathologies. For example, certain combinations of EVT-specific HLA-C molecules and uNK cell-associated killer immunoglobulin-like receptor haplotypes greatly enhance the risk of developing preeclampsia (Hiby et al., 2004) . Likewise, increased amounts of M1 macrophages seem to exert adverse effects such as the secretion of proinflammatory cytokines, a hallmark of preeclampsia (Schonkeren et al., 2011) . Well in line, a recent publication suggests that the impaired trophoblast phenotype noticed in preeclamptic patients can at least in part be attributed to the uterine environment (Zhou et al., 2013) . This conclusion was drawn upon the observation that preeclampsia-associated alterations in trophoblast gene expression returned to control values after cultivating trophoblast cells for two days in vitro. In the light of our data, it would be highly interesting to quantify apoptosis rates and to assess ErbB2/ErbB3 expression in cell columns of preeclamptic placentas.
Furthermore, it is tempting to speculate that a reduction of NRG1 activity may sensitize trophoblast cells to apoptosis. Hence, we propose that determination of NRG1 levels in DSCs from healthy and compromised pregnancies certainly deserves further attention in future research.
In conclusion, by showing that NRG1-dependent ErbB2/ErbB3 signalling is essential for survival of differentiated trophoblast cell populations, we add a novel physiological role of this cancer-associated receptor combination during human development.
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Materials and Methods
Tissue collection
First trimester placental (n = 60) and decidual (n = 9) specimens were obtained from elective terminations of viable pregnancies between the 6 th and 12 th gestational week. The gestational age was determined by ultrasound. Patients were locally anaesthetized and treated with misoprostol before surgical intervention. Tissues were collected with written informed consent and utilization was approved by the Ethics Committee of the Medical University of Vienna.
Isolation of human primary trophoblasts
Primary trophoblasts were isolated from first trimester placental tissue as described (Fock et al., 2015) . Briefly, placental villi were scraped and digested twice in 0. Finally, trophoblasts were seeded onto fibronectin-coated (20 μg/ml; Millipore, Temecula, CA) dishes at a density of 5 x 10 5 cells/24-well.
Isolation of human primary DSCs
First trimester DSCs were isolated as described . Briefly, decidual tissue was minced and digested three times in 2 mg/ml collagenase I (Gibco ® ) and 0.5 mg/ml DNase I for 20 min under agitation at 37°C. Dispersed cells were pooled and filtered through a 100 μm cell strainer. After red blood cell lysis, cells were plated on plastic dishes for 24 h, followed by harvesting of serum-free conditioned medium and cell lysis. Samples were processed for RT-PCR and/or Western blotting.
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Cell signalling
To investigate the activation of signalling mediators, overnight-cultivated primary trophoblasts were serum-starved for 4 h and stimulated with rhu NRG1 (20 ng/ml, Cell
Signaling Technology, Danvers, MA) or DSC-conditioned medium for 5 and 20 min. When indicated, ErbB2 and ErbB3 single-or ErbB2/ErbB3 double-knockdowns were performed or cells were pre-incubated with an anti-ErbB3 monoclonal antibody (10 µg/ml; R&D Systems, Minneapolis, MN) for 30 min. A citrate solution (4 µM) and an IgG mAb (10 µg/ml; Cell
Signaling Technology) were used as vehicle control. Cells were lysed in Laemmli buffer and subjected to Western blotting. Samples for the PathScan® RTK Signaling Antibody Array Kit (Cell Signaling Technology) were processed according to the manufacturer's instructions.
Signals were detected by chemiluminescence and pixel intensities were determined by densitometry using Alpha View 3.1.1.0 software (Alpha Innotech, San Leandro, CA).
Real-time PCR
Cells were lysed in peqGOLD TriFast TM (PEQLAB, Erlangen, Germany) and RNA was extracted according to the manufacturer's instructions. RNA amount and purity were assessed with a ND-1000 NanoDrop spectrophotometer (PEQLAB Images were acquired on a BX50 fluorescence microscope equipped with a CC12 digital camera and Cell^P software (Olympus, Hamburg, Germany).
Flow cytometry
Single cell suspensions of primary overnight-cultivated trophoblasts were obtained by Accutase (PAA Laboratories) treatment for 5 min at 37°C. Cells were resuspended in ice-cold PBS containing 2% BSA (Sigma-Aldrich) and labelled with FITC-and PE-conjugated antibodies outlined in Supplementary Table 1 for 20 min at 4°C. Appropriate isotype-specific control antibodies were used accordingly. Data were acquired on a FACScan flow cytometer (BD Biosciences, Franklin Lakes, NJ) and analyzed with FlowJo 7.6.4 software (Tree Star, Ashland, OR).
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Freshly isolated primary trophoblasts were transfected with SMARTpool ® ON-TARGETplus siRNAs (GE Dharmacon, Lafayette, CO) using Lipofectamine ® RNAiMAX reagent (Invitrogen TM , Life Technologies) according to the manufacturer's instructions. The following siRNAs were used at a concentration of 40 nM: ErbB2 (L-003126-00-0005), ErbB3 (L-003127-00-0005) and non-targeting control (D-001810-10-05). After 48 h, transfected cells were subjected to Western blotting.
EVT formation assay
Placental villi (7 th -9 th gestational week) were dissected and placed on Collagen-I drops (Corning) as described . After 5 h, placental explants were covered with DMEM/Ham's F-12 medium supplemented with 0.05 mg/ml gentamicin and further incubated for 24 h in the presence or absence of rhu NRG1 (2, 20 or 200 ng/ml). A citrate solution (4 µM) was used as vehicle control. The area of outgrowth was digitally photographed on a BX50 fluorescence microscope and quantified using Cell^P software.
RNA was extracted by lysing explants in peqGOLD TriFast TM subsequent to the removal of anchoring villi. Pooled RNA of control-or rhu NRG1-treated trophoblast cell columns was subjected to RT-PCR for monitoring the influence of rhu NRG1 on EVT marker expression.
Since EGFR + CCTs are non-responsive to NRG1 due to a lack of ErbB3 expression, gene expression levels were normalized to EGFR mRNA values (set to 1).
CPT-induced apoptosis
Primary trophoblasts and dissected placental villi (7 th -9 th gestational week, n = 15 per condition) were cultivated in DMEM/Ham's F-12 medium supplemented with 0.05 mg/ml gentamicin for 24 h. Placental villi were selected for the presence of attached cell columns under a light microscope. Subsequently, trophoblast cells or floating explants were preincubated with an ErbB3 mAb (10 µg/ml) for 30 min, followed by the addition of rhu NRG1
(20 ng/ml) and treatment with CPT (1 µM; MP Biomedicals, Santa Ana, CA) for 5 h, before being processed for Western blotting or immunofluorescence stainings, respectively. A citrate solution (4 µM), DMSO (10 µM) and an IgG mAb (10 µg/ml) were used as vehicle control. 
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